Analysis of Cardiac Biomarker Racial Discrepancies

Withdrawn before enrolling

Conditions studied: Heart Failure

In brief

The goal is to review cardiac biomarkers present on admission between African American patients with new onset Heart Failure compared to a comparable cohort of Caucasian patients to establish whether there is a clinically significant difference between the two groups regarding cardiac biomarker levels and initial Heart Failure severity. Hypothesis: Cardiac biomarker levels in African American patients with new onset Heart Failure with Reduced Ejection Fraction will be significantly lower than a Caucasian cohort with new onset Heart Failure with Reduced Ejection Fraction.

Key facts

Study ID

NCT05224557

Run by

Methodist Health System

People needed

0

Starts

2021-09-15

Expected to finish

2028-09-15

Last updated by the study team

2026-08-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• >18 years
• Self-identified as AA
• Self-identified as Caucasian
• NYHA class II-IV symptoms
• Left ventricle EF <40%
• First admission for HFrEF
• No echocardiography during initial admission

You may not qualify if…

• Patients not meeting inclusion criteria

Where it is running

• Methodist Dallas Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.